Opinion|Videos|May 3, 2024

LITESPARK-005: Belzutifan in Previously Treated Advanced Clear Cell RCC

Following a review of the LITESPARK-005 trial, experts on renal cell carcinoma discuss the potential role of belzutifan in the treatment algorithm.


Latest CME